BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7828155)

  • 1. Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters.
    Cigudosa JC; Calasanz MJ; Odero MD; Prosper F; Etxaniz A; Marin J; Rifón J; Gullón A; Rocha E
    Cancer Genet Cytogenet; 1994 Dec; 78(2):210-3. PubMed ID: 7828155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
    Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.
    Clark RE; Geddes AD; Whittaker JA; Jacobs A
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1789-93. PubMed ID: 2632260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
    Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotype in multiple myeloma and plasma cell leukaemia.
    Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
    Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases.
    Smadja NV; Fruchart C; Isnard F; Louvet C; Dutel JL; Cheron N; Grange MJ; Monconduit M; Bastard C
    Leukemia; 1998 Jun; 12(6):960-9. PubMed ID: 9639426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
    Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
    Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
    Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
    Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
    Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of G banded karyotypes in myeloma cells.
    Chen KC; Bevan PC; Matthews JG
    J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome findings in multiple myeloma.
    Ranni NS; Slavutsky I; Wechsler A; Brieux de Salum S
    Cancer Genet Cytogenet; 1987 Apr; 25(2):309-16. PubMed ID: 3470119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients].
    Jarosová M; Scudla V; Indrák K; Kapustová M
    Vnitr Lek; 1990 Nov; 36(11):1072-80. PubMed ID: 2267737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities.
    Tricot G; Barlogie B; Jagannath S; Bracy D; Mattox S; Vesole DH; Naucke S; Sawyer JR
    Blood; 1995 Dec; 86(11):4250-6. PubMed ID: 7492784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypodiploidy is a major prognostic factor in multiple myeloma.
    Smadja NV; Bastard C; Brigaudeau C; Leroux D; Fruchart C;
    Blood; 2001 Oct; 98(7):2229-38. PubMed ID: 11568011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.